Benjamin Jolley

I sat down with Benjamin Jolley, a third-generation pharmacist who recently addressed a crowd of 20,000 about the broken world of PBMs. We dug into the power of that moment, the hidden mechanics of pharmacy monopolies, and what real reform could look like. This one hits where policy meets reality.

In this episode of "The Business of Pharmacy Podcast," host Mike Koelzer is joined by industry experts Antonio Ciaccia, Benjamin Jolley, and Luke Slindee to discuss the complex world of Pharmacy Benefit Managers (PBMs). Antonio Ciaccia, president of Three Axis Advisors, Benjamin Jolley, pharmacist and Senior Fellow at the American Economic Liberties Project, and Luke Slindee, a second-generation pharmacist, bring their insights into the conversation. The discussion kicks off with the upcoming co...

Luke Slindee and Benjamin Jolley, PharmDs, discuss the FTC Inquiry into PBMs. https://benjaminjolley.substack.com/

The guests on the show, Luke Slindee and Benjamin Jolley, are both pharmacists interested in pharmacy pricing and the pharmacy supply chain. The business model of Amazon is similar to that of pharmacy benefit managers (PBMs) in terms of monopoly power and the abuse of large corporations against smaller businesses and consumers. The doctrine of antitrust enforcement has changed from "harmful dominance" to a focus on consumer welfare, which has led to a lack of attention on the impact on smaller b...

DIR expert, Benjamin Jolley, PharmD, discusses effective counterpunches that can be used against the pharmacy benefit managers

Benjamin Jolley, PharmD is an independent pharmacist helping pharmacy owners understand and gain control over current contracting, especially DIR & GER. www.calendly.com/dir-fees